SCHEMBL15547406

SCHEMBL15547406

C1=Cc2ccccc2C(=C2C=Cc3ccccc32)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 2/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
BCHE P06276 1/20 0.36
POLB P06746 1/20 0.36
PTPRC P08575 1/20 0.36
THRB P10828 1/20 0.36
PKM P14618 1/20 0.36
IDO1 P14902 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
PTPN1 P18031 1/20 0.36
ACHE P22303 1/20 0.36
CES1 P23141 1/20 0.36
RECQL P46063 1/20 0.36
PTPN22 Q9Y2R2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9617411 0.75 LMNA (0.50) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL15558588 0.74 CA1 (0.40) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL813542 0.73 MAOA (0.46) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL813544 0.73 MAOA (0.46) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL29422894 0.72 ALDH1A1 (0.35) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL7214854 0.72 ALDH1A1 (0.38) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL15558221 0.71 SETD7 (0.35) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL15548375 0.71 PTPN1 (0.33) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL15548371 0.71 PTPN1 (0.33) ALDH1A1HSD17B10MEN1LMNAMAPT
SCHEMBL979267 0.71 CES1 (0.40) ALDH1A1HSD17B10MEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284621-A1 CANNABINOIDS AND USES THEREOF CORBUS PHARMACEUTICALS, INC. 2021-09-16 US disclosed
EP-3801505-A1 CANNABINOIDS AND USES THEREOF Corbus Pharmaceuticals, Inc. (US) 2021-04-14 EP disclosed
US-20170240521-A1 PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-08-24 US disclosed
US-9656981-B2 Peripherally-acting cannabinoid receptor agonists for chronic pain THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-05-23 US disclosed
US-20150239859-A1 PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2015-08-27 US disclosed
WO-2014015298-A1 PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-01-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210284621-A1 CANNABINOIDS AND USES THEREOF CNR2, CNR1, FAAH ALDH1A1 2486/4885HSD17B10 2000/4885MEN1 2697/4885
US-20150239859-A1 PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN CNR2, CNR1, OPRL1 ALDH1A1 3666/4885HSD17B10 3930/4885MEN1 4854/4885
US-20170240521-A1 PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN CNR2, CNR1, OPRL1 ALDH1A1 3666/4885HSD17B10 3930/4885MEN1 4854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.